David P. Baccanari

2.5k total citations
48 papers, 2.1k citations indexed

About

David P. Baccanari is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, David P. Baccanari has authored 48 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 13 papers in Infectious Diseases and 13 papers in Organic Chemistry. Recurrent topics in David P. Baccanari's work include Biochemical and Molecular Research (16 papers), HIV/AIDS drug development and treatment (10 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). David P. Baccanari is often cited by papers focused on Biochemical and Molecular Research (16 papers), HIV/AIDS drug development and treatment (10 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). David P. Baccanari collaborates with scholars based in United States, United Kingdom and Poland. David P. Baccanari's co-authors include Lee F. Kuyper, Robert L. Tansik, Barbara Roth, S S Joyner, James J. Burchall, Barbara S. Rauckman, Stephen T. Davis, Sheila L. Smith, David A. Stone and V C Knick and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

David P. Baccanari

48 papers receiving 1.9k citations

Peers

Countries citing papers authored by David P. Baccanari

Since Specialization

Citations

This map shows the geographic impact of David P. Baccanari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David P. Baccanari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David P. Baccanari more than expected).

Fields of papers citing papers by David P. Baccanari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David P. Baccanari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David P. Baccanari. The network helps show where David P. Baccanari may publish in the future.

Co-authorship network of co-authors of David P. Baccanari

This figure shows the co-authorship network connecting the top 25 collaborators of David P. Baccanari. A scholar is included among the top collaborators of David P. Baccanari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David P. Baccanari. David P. Baccanari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	α-Fluoro-β-alanine: Effects on the antitumor activity and toxicity of 5-fluorouracil 2000 ·Biochemical Pharmacology ·Shousong Cao, David P. Baccanari, Youcef M. Rustum, Stephen T. Davis, Robert L. Tansik, David Porter, Thomas Spector	21
2	Preclinical Development of Eniluracil: Enhancing the Therapeutic Index and Dosing Convenience of 5-Fluorouracil 2000 ·Investigational New Drugs ·Melanie Paff, David P. Baccanari, Stephen T. Davis, Shousong Cao, Robert L. Tansik, Y M Rustum, Thomas Spector	9
3	Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecan. 2000 ·PubMed ·David L. Emerson, Raymond A. Bendele, Eric Brown, (unknown), John Desjardins, (unknown), Stanley C. Gill, Marta Hamilton, (unknown), L Moon-McDermott, (unknown), Frank C. Richardson, Blake Tomkinson, Michael J. Luzzio, David P. Baccanari	51
4	Inhibitors of dihydrofolate reductase: Design, synthesis and antimicrobial activities of 2,4‐diamino‐6‐methyl‐5‐ethynylpyrimidines 1999 ·Journal of Heterocyclic Chemistry ·Michael L. Jones, David P. Baccanari, Robert L. Tansik, (unknown), Sharon K. Rudolph, Lee F. Kuyper	4
5	Peptide agonists of the thrombopoietin receptor 1998 ·Stem Cells ·William J. Dower, Steven E. Cwirla, Balasubramanian Palaniappan, Peter J. Schatz, Ronald W. Barrett, David P. Baccanari	20
6	X-ray Crystallographic Studies of Candida albicans Dihydrofolate Reductase 1997 ·Journal of Biological Chemistry ·Marc Whitlow, Andrew Howard, David B. Stewart, Karl D. Hardman, Lee F. Kuyper, David P. Baccanari, Mary E. Fling, Robert L. Tansik	60
7	Inhibition of Uridine Phosphorylase. Synthesis and Structure−Activity Relationships of Aryl-Substituted 1-((2-Hydroxyethoxy)methyl)-5-(3-phenoxybenzyl)uracil 1997 ·Journal of Medicinal Chemistry ·G. Faye Orr, David L. Musso, James L. Kelley, S S Joyner, Stephen T. Davis, David P. Baccanari	7
8	Synthesis of 1,3‐diamino‐7,8,9,10‐tetrahydropyrido[3,2‐f]‐quinazolines. Inhibitors of Candida albicans dihydrofolate reductase as potential antifungal agents 1997 ·Journal of Heterocyclic Chemistry ·Joseph H. Chan, David P. Baccanari, Robert L. Tansik, (unknown), Sharon K. Rudolph, Andrew D. Brown, (unknown), Lee F. Kuyper, Michael Jones	41
9	Pyrrolo[2,3-d]pyrimidines and pyrido[2,3-d]pyrimidines as conformationally restricted analogues of the antibacterial agent trimethoprim 1996 ·Bioorganic & Medicinal Chemistry ·Lee F. Kuyper, (unknown), David P. Baccanari, J.N. Champness, D.K. Stammers, C.R. Beddell	44
10	Dihydropyrimidine dehydrogenase inactivation and 5-fluorouracil pharmacokinetics: allometric scaling of animal data, pharmacokinetics and toxicodynamics of 5-fluorouracil in humans 1996 ·Cancer Chemotherapy and Pharmacology ·S P Khor, (unknown), Stephen T. Davis, Donald J. Nelson, David P. Baccanari, Thomas Spector	17
11	High-Affinity Inhibitors of Dihydrofolate Reductase: Antimicrobial and Anticancer Activities of 7,8-Dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with Small Molecular Size 1996 ·Journal of Medicinal Chemistry ·Lee F. Kuyper, David P. Baccanari, Michael L. Jones, R. Hunter, Robert L. Tansik, S S Joyner, (unknown), Sharon K. Rudolph, V C Knick, H. R. Wilson, (unknown), Henry S. Friedman, John C.W. Comley, Jeremy N. Stables	96
12	Inhibition of uridine phosphorylase: synthesis and structure-activity relationships of aryl-substituted 5-benzyluracils and 1-[(2-hydroxyethoxy)methyl]-5-benzyluracils. 1995 ·Journal of Medicinal Chemistry ·G. Faye Orr, David L. Musso, (unknown), James L. Kelley, S S Joyner, Stephen T. Davis, David P. Baccanari	8
13	Selective Inhibitors of Candida albicans Dihydrofolate Reductase: Activity and Selectivity of 5-(Arylthio)-2,4-diaminoquinazolines 1995 ·Journal of Medicinal Chemistry ·Joseph H. Chan, (unknown), Lee F. Kuyper, David P. Baccanari, S S Joyner, Robert L. Tansik, (unknown), Sharon K. Rudolph	63
14	Species-dependent differences in the biochemical effects and metabolism of 5-benzylacyclouridine 1993 ·Biochemical Pharmacology ·Stephen T. Davis, S S Joyner, (unknown), David P. Baccanari	11
15	Refolding of Recombinant Pneumocystis carinii Dihydrofolate Reductase and Characterization of the Enzyme 1993 ·Protein Expression and Purification ·C. J. Delves, S. Ballantine, Robert L. Tansik, David P. Baccanari, D.K. Stammers	17
16	2,4-Diamino-5-benzylpyrimidines and analogs as antibacterial agents. 12. 1,2-Dihydroquinolylmethyl analogs with high activity and specificity for bacterial dihydrofolate reductase 1989 ·Journal of Medicinal Chemistry ·(unknown), Barbara S. Rauckman, David P. Baccanari, Barbara Roth	179
17	2,4-Diamino-5-benzylpyrimidines as antibacterial agents. 13. Some alkenyl derivatives with high in vitro activity against anaerobic organisms 1989 ·Journal of Medicinal Chemistry ·Barbara Roth, (unknown), Robert Ferone, David P. Baccanari, Carl W. Sigel, (unknown), Lynn P. Elwell	9
18	Substrate-inhibitor cooperative interactions with microbial dihydrofolate reductases 1987 ·Advances in Enzyme Regulation ·David P. Baccanari, Robert L. Tansik, George H. Hitchings	4
19	Methotrexate analogs. 30. Dihydrofolate reductase inhibition and in vitro tumor cell growth inhibition by N.epsilon.-(haloacetyl)-L-lysine and N.delta.-(haloacetyl)-L-ornithine analogs and an acivicin analog of methotrexate 1987 ·Journal of Medicinal Chemistry ·A. Rosowsky, (unknown), Ronald A. Forsch, Tavner J. Delcamp, David P. Baccanari, James H. Freisheim	8
20	Coupled oxidation of NADPH with thiols at neutral pH 1978 ·Archives of Biochemistry and Biophysics ·David P. Baccanari	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact